human
immunodefici
viru
type
gain
entri
host
cell
fusion
viral
envelop
membran
host
cell
membran
process
gener
initi
bind
envelop
glycoprotein
host
cell
surfac
bind
induc
conform
chang
allow
interact
cellular
surfac
chemokin
receptor
term
coreceptor
use
mani
type
chemokin
receptor
coreceptor
two
common
type
coreceptor
entri
variant
requir
infect
isol
vitro
vivo
coreceptor
bind
site
variant
expos
bind
directli
interact
coreceptor
entri
report
cell
liver
kidney
cell
infect
aid
patient
variant
thought
associ
hepat
nephropathi
cell
dysfunct
aid
patient
almost
simpl
retrovirus
includ
murin
leukemia
virus
mlv
recogn
multipl
membranespan
protein
coreceptor
variant
simian
immunodefici
viru
isol
frequent
variant
recogn
sole
receptor
isol
result
suggest
variant
prototyp
strain
inhibitor
endosom
acidif
attenu
infect
mani
retrovirus
includ
mlv
avian
leukosi
viru
jaagsiekt
sheep
retroviru
equin
infecti
anemia
viru
foami
viru
recent
report
inhibitor
endosom
cathepsin
proteas
attenu
ecotrop
mlv
infect
result
indic
entri
retrovirus
occur
acid
late
endosom
requir
endosom
cathepsin
proteas
ebola
viru
reoviru
japanes
enceph
viru
coronaviru
cathepsin
proteas
activ
low
ph
acid
endosom
endosom
acidif
inhibitor
might
attenu
viru
infect
suppress
cathepsin
proteas
activ
howev
endosom
acidif
inhibitor
suppress
infect
rather
enhanc
therefor
entri
like
occur
host
cell
surfac
endosom
howev
recent
shown
enter
host
cell
via
endosom
due
conflict
observ
unclear
whether
entri
occur
endosom
direct
fusion
cell
surfac
membran
mndk
strain
isol
adapt
parent
ndk
viru
cell
mndk
variant
infect
induc
syncytia
cell
howev
mndk
viru
effici
infect
cell
cell
suggest
mndk
viru
induc
depend
infect
posit
cell
respect
present
studi
found
hela
cell
much
less
suscept
infect
vector
mndk
viru
envelop
protein
env
cell
hybridoma
cell
hela
cell
suscept
mndk
vector
infect
cell
indic
hela
cell
lack
cellular
factor
requir
mndk
vector
infect
aim
identifi
cellular
factor
screen
cdna
express
librari
prepar
human
lymph
node
cystatin
c
inhibit
cystein
cathepsin
proteas
isol
enhanc
mndk
vector
infect
hela
cell
synthet
cathepsin
b
inhibitor
also
enhanc
mndk
vector
infect
hela
cell
affect
infect
result
show
cathepsin
b
inhibit
vector
infect
cathepsin
proteas
activ
low
ph
acid
late
endosom
mndk
infect
might
occur
endosom
inhibitor
endosom
acidif
endocytosi
significantli
attenu
vector
infect
infect
expect
result
suggest
enter
acid
late
endosom
assess
suscept
hela
cell
vector
contain
mndk
env
protein
transduct
titer
vector
measur
cell
transduct
titer
vsvg
mndk
envbear
vector
cell
cell
respect
fig
left
panel
normal
titer
vsv
vector
suscept
cell
mndk
vector
infect
cell
transduct
titer
vsv
mndk
vector
hela
cell
cell
respect
normal
titer
vsv
vector
indic
suscept
hela
cell
mndk
vector
infect
cell
howev
cell
engin
express
cell
found
suscept
mndk
vector
infect
cell
fig
right
panel
infect
receptor
infect
mndk
vector
cell
surfac
express
cell
analyz
result
hela
cell
express
effici
cell
fig
result
indic
hela
cell
either
possess
inhibitori
factor
lack
factor
necessari
mndk
vector
infect
determin
whether
posit
neg
factor
involv
resist
phenotyp
hela
cell
hybridoma
cell
hela
cell
construct
hela
cell
inocul
puromycin
resist
geneencod
mlv
vector
construct
drugresist
cell
cell
origin
geneticinresist
puromycinresist
hela
cell
fuse
geneticinresist
cell
polyethylen
glycol
hybridoma
cell
obtain
coselect
puromycin
geneticin
doubl
antibioticsresist
cell
pool
use
follow
studi
four
independ
hybridoma
cell
pool
suscept
mndk
vector
infect
cell
fig
show
hela
cell
lack
cellular
factor
requir
mndk
vector
infect
identifi
cellular
factor
requir
mndk
vector
infect
hela
cell
transfect
cdna
express
librari
construct
human
lymph
node
report
human
lymph
node
cell
includ
tlymphocyt
highli
suscept
variant
plasmid
vector
use
cdna
librari
construct
contain
neomycinresist
gene
transfect
hela
cell
select
geneticin
geneticinresist
hela
cell
inocul
mndk
vector
contain
blasticidinresist
gene
select
marker
mndk
vector
dilut
obtain
one
blasticidinresist
cell
coloni
normal
hela
cell
per
cultur
dish
experi
repeat
seven
time
final
six
blasticidinresist
cell
clone
obtain
among
blasticidinresist
cell
clone
one
cell
clone
time
suscept
lacz
geneencod
mndk
vector
infect
parent
hela
cell
fig
suscept
blasticidinresist
cell
clone
almost
origin
hela
cell
obtain
cdna
fragment
express
cell
pcr
perform
use
genom
dna
prepar
cell
pcr
primer
complementari
flank
region
cdna
insert
cdna
librari
plasmid
result
approxim
pcr
fragment
detect
fig
partial
sequenc
indic
cystatin
c
endogen
cystatin
c
mrna
long
encod
acid
protein
cystatin
c
protein
abundantli
express
mani
tissu
inhibit
cystein
proteas
activ
express
cystatin
c
protein
cell
analyz
western
immunoblot
use
anticystatin
c
antibodi
fig
cystatin
c
mrna
detect
hela
cell
fig
confirm
role
cystatin
c
mndk
vector
infect
hela
cell
stabli
express
cystatin
c
construct
use
mlv
vector
encod
cystatin
c
hela
cell
express
cystatin
c
time
suscept
mndk
vector
infect
control
hela
cell
transduc
empti
mlv
vector
fig
upper
panel
cystatin
c
express
also
enhanc
infect
effect
infect
less
infect
cystatin
c
protein
express
transduc
cell
confirm
western
immunoblot
fig
lower
panel
cystatin
c
express
result
enhanc
suscept
cell
vector
infect
affect
suscept
cell
cystatin
c
express
affect
mndk
vector
infect
cell
cystatin
c
affect
cell
surfac
express
hela
cell
fig
indic
cystatin
c
increas
vector
infect
enhanc
express
collect
find
indic
cystatin
c
enhanc
mndk
vector
infect
hela
cell
cell
next
quantit
measur
cathepsin
b
activ
hela
cell
see
materi
method
cathepsin
b
activ
highest
hela
cell
follow
order
cell
fig
b
target
cell
express
higher
level
cathepsin
b
activ
less
suscept
mndk
vector
infect
suggest
cathepsin
b
inhibit
infect
cystatin
c
express
inde
reduc
cathepsin
b
activ
hela
cell
fig
cystatin
c
neither
inhibit
cathepsin
b
activ
enhanc
vector
infect
cell
fig
probabl
cathepsin
b
activ
cell
origin
low
address
whether
cystatin
c
enhanc
vector
infect
inhibit
cathepsin
proteas
activ
effect
synthet
cathepsin
proteas
inhibitor
vector
infect
analyz
target
cell
pretreat
cathepsin
inhibitor
h
expect
hela
cell
treat
specif
cathepsin
b
inhibitor
transduct
titer
mndk
vector
increas
fig
similarli
treatment
cell
induc
enhanc
infect
associ
chang
cathepsin
b
activ
inde
reduc
treatment
hela
cell
level
similar
control
cell
fig
result
indic
cathepsin
b
inhibit
cystatin
c
lead
enhanc
vector
infect
suggest
cathepsin
b
play
role
suppress
infect
hela
cell
express
cathepsin
b
rel
higher
level
contrast
treatment
attenu
vector
infect
dosedepend
manner
cell
fig
whose
cathepsin
b
activ
extrem
low
fig
b
cell
treat
lower
concentr
see
whether
vector
infect
would
promot
treatment
cell
cathepsin
b
activ
slightli
inhibit
dmsotreat
cell
cell
treat
lower
concentr
cathepsin
b
activ
treat
cell
affect
infect
enhanc
treatment
affect
mndk
vector
infect
cell
cathepsin
l
specif
inhibitor
affect
mndk
vector
infect
cell
data
shown
result
suggest
cathepsin
b
activ
reversecorrel
suscept
mndk
vector
infect
hela
cell
confirm
result
suscept
infect
cathepsin
b
activ
two
cell
line
cell
measur
surprisingli
mndk
vectorinfect
cell
detect
cell
fig
cathepsin
b
activ
cell
higher
hela
cell
fig
treatment
confer
cell
suscept
mndk
vector
infect
fig
suggest
cell
complet
resist
infect
due
high
level
cathepsin
b
activ
howev
cell
less
suscept
vsvgpseudotyp
vector
infect
cell
fig
infect
resist
cell
like
involv
postentri
mechan
either
cell
suscept
mndk
vector
infect
cell
similar
level
cathepsin
b
activ
cell
fig
b
treatment
cell
enhanc
infect
time
like
cell
fig
statist
analysi
reveal
suscept
mndk
vector
infect
reversecorrel
cathepsin
b
activ
target
cell
fig
result
strongli
support
conclus
cathepsin
b
one
critic
cellular
factor
determin
suscept
infect
result
indic
cathepsin
b
inhibit
mndk
vector
infect
cell
high
cathepsin
b
activ
confirm
cathepsin
b
inhibit
vector
infect
effect
cathepsin
b
overexpress
vector
infect
analyz
cell
cathepsin
b
express
low
level
cell
inocul
mlv
vector
encod
cathepsin
b
puromycinresist
gene
select
puromycin
puromycinresist
cell
pool
inde
elev
level
cathepsin
b
activ
compar
control
cell
fig
cathepsin
b
overexpress
significantli
inhibit
vector
infect
infect
fig
cathepsin
boverexpress
cell
treat
vector
infect
enhanc
fig
hela
cell
result
suggest
cathepsin
b
host
defens
factor
infect
infect
report
lp
treatment
cell
enhanc
cathepsin
b
express
therefor
activ
innat
immun
lpsmediat
signal
might
attenu
infect
address
hypothesi
cell
origin
express
cathepsin
b
low
level
fig
transfect
express
plasmid
construct
research
group
fusion
protein
extracellular
domain
intracellular
domain
function
constitut
activ
mutant
nf
b
activ
transfect
cell
express
plasmid
observ
data
shown
extracellular
domain
deriv
mous
directli
affect
vector
infect
expect
signal
activ
reduc
vector
infect
cell
fig
left
panel
transfect
affect
infect
hela
cell
cathepsin
b
origin
express
high
level
transfect
affect
vector
infect
cell
fig
right
panel
inhibitori
effect
infect
abrog
treatment
cathepsin
b
inhibitor
fig
plasmid
transfect
inde
enhanc
cathepsin
b
mrna
express
analyz
rtpcr
fig
cathepsin
b
activ
cell
fig
result
indic
signal
activ
induc
cathepsin
b
express
render
cell
resist
infect
suggest
cathepsin
b
function
innat
immun
factor
infect
result
indic
cathepsin
b
attenu
mndk
vector
infect
cell
high
cathepsin
b
activ
infect
cathepsin
b
activ
low
ph
acid
endosom
mndk
vector
might
enter
host
cell
acid
endosom
enter
host
cell
acid
endosom
cathepsin
b
might
effect
infect
examin
possibl
effect
endosom
acidif
inhibitor
bafilomycin
chloroquin
vector
infect
analyz
target
cell
pretreat
inhibitor
h
vector
inocul
treatment
fig
fig
hela
fig
cell
inhibitor
attenu
mndk
vector
infect
dosedepend
manner
contrast
fig
mndk
vector
data
shown
infect
inhibit
inhibitor
cell
actual
increas
hela
cell
previous
report
higher
concentr
inhibitor
requir
inhibit
vector
infect
hela
cell
cell
correl
level
cathepsin
b
activ
cell
chloroquin
treatment
cell
reduc
cathepsin
b
activ
cell
lysat
prepar
treat
cell
fig
left
panel
howev
chloroquin
ad
cell
lysat
cathesin
b
activ
reduc
fig
right
panel
cathepsin
proteas
activ
endosom
acidif
endosom
acidif
inhibitor
treatment
cell
suppress
cathepsin
b
activ
cathepsin
activ
treatment
inhibitor
reduc
cell
surfac
express
fig
indic
abrog
infect
endosom
acidif
inhibitor
due
suppress
express
result
indic
infect
requir
endosom
acidif
occur
acid
late
endosom
result
suggest
particl
intern
endocytosi
infect
assess
hypothesi
effect
endocytosi
inhibitor
dynasor
domin
neg
mutant
depend
vector
infect
analyz
target
cell
pretreat
dynasor
h
dynasor
inhibit
dynamin
gtpase
clathrindepend
endocytosi
dynasor
treatment
effici
attenu
mndk
vector
infect
mndk
fig
data
shown
vector
infect
examin
cell
p
dynasor
treatment
affect
cell
surfac
express
fig
demonstr
dynasor
treatment
attenu
infect
mechan
suppress
express
dynasor
treatment
target
cell
moder
attenu
cathepsin
b
activ
fig
left
panel
howev
dynasor
ad
cell
lysat
cathepsin
b
activ
affect
fig
right
panel
inhibit
endocytosi
dynasor
might
suppress
cathepsin
b
activ
reduc
number
endosom
treat
cell
activ
cathepsin
b
present
late
endosom
dynasor
treatment
inhibit
endocytosi
transferin
expect
fig
howev
chloroquin
treatment
result
suggest
chloroquin
treatment
inhibit
vector
infect
mechan
endocytosi
suppress
involv
endosytosi
domin
neg
mutant
suppress
endocytosi
tag
gfp
express
transfect
cell
analyz
flow
cytometri
suppress
mndk
infect
infect
fig
condit
level
express
cell
similar
fig
cell
rather
enhanc
vector
infect
provabl
due
elev
express
fig
express
hela
cell
affect
result
indic
endocytosi
profoundli
involv
infect
infect
result
indic
endosom
acidif
endocytosi
cathepsin
b
activ
involv
mndk
envmedi
infect
assess
whether
cellular
event
also
involv
anoth
infect
vector
contain
env
protein
rodb
strain
construct
seen
mndk
infect
rodb
infect
enhanc
treatment
cell
fig
endosom
acdif
inhibitor
chloroquin
endocytosi
inhibitor
dynasor
suppress
rodb
infect
infect
result
indic
endosom
acidif
endocytosi
cathepsin
b
activ
involv
mndk
infect
also
rodb
infect
inhibit
cathepsin
b
activ
cystatin
c
express
specif
inhibitor
cathepsin
b
significantli
enhanc
vector
infect
hela
cell
express
cathepsin
b
rel
higher
level
cathepsin
b
activ
invers
correl
cellular
suscept
vector
infect
overexpress
cathepsin
b
attenu
vector
infect
cell
signal
activ
also
attenu
vector
infect
enhanc
cathepsin
b
express
result
indic
cathepsin
b
one
host
innat
immun
factor
resist
infect
endocytosi
inhibitor
dynasor
suppress
vector
infect
show
infect
occur
endosom
mechan
cathepsin
b
inhibit
infect
suggest
follow
higher
cathepsin
b
proteas
activ
hela
cell
caus
degrad
particl
acid
endosom
attenu
infect
fig
inhibit
cathepsin
b
cystatin
c
express
treatment
increas
infect
suppress
viral
particl
degrad
sinc
cystatin
c
express
cell
cystatin
c
may
factor
necessari
infect
cell
howev
cathepsin
b
clearli
inhibitori
effect
infect
cathepsin
b
activ
cell
extrem
low
cell
could
anoth
factor
suppress
cathepsin
b
activ
express
hela
cell
anoth
cystatin
member
cystatin
b
report
associ
higher
suscept
monocytederiv
macrophag
infect
compar
placent
macrophag
cystatin
b
local
predominantli
cytoplasm
cystatin
c
gener
locat
late
endosom
secret
cystatin
c
affect
infect
studi
role
cystatin
b
c
infect
differ
endosom
acidif
inhibitor
also
known
attenu
infect
mani
retrovirus
indic
retroviru
infect
occur
acid
endosom
studi
infect
attenu
chloroquin
dynasor
strongli
indic
infect
occur
acid
endosom
case
retrovirus
fig
contrast
inhibitor
less
effici
attenu
vector
infect
infect
previou
report
suggest
infect
occur
acid
endosom
howev
miyauchi
et
al
recent
report
enter
host
cell
via
endosom
particl
might
intern
dynaminindepend
endocytosi
even
particl
intern
endosom
product
infect
entri
might
occur
particlebear
endosom
becom
acid
late
endosom
fig
studi
need
clarifi
issu
endosom
acidif
inhibitor
thought
enhanc
vector
infect
suppress
cathepsin
b
activ
cathepsin
b
activ
low
ph
acid
endosom
inde
endosom
acidif
inhibitor
reduc
cathepsin
b
activ
inhibit
cathepsin
b
activ
treatment
enhanc
vector
infect
hela
cell
endosom
acidif
inhibitor
much
less
effici
attenu
cathepsin
b
activ
endosom
acidif
inhibitor
could
enhanc
infect
result
suggest
endosom
acidif
directli
involv
entri
case
influenza
viru
vsv
signal
activ
attenu
vector
infect
enhanc
cathepsin
b
express
suggest
cathepsin
b
function
innat
immun
factor
resist
endosom
cathepsin
proteas
degrad
microb
invad
host
cell
gener
peptid
present
mhc
class
ii
order
protect
host
microb
context
interest
sever
microb
encod
cathepsin
proteas
inhibitor
homolog
cystatin
famili
microbi
cystatin
inhibit
host
innat
adapt
immun
mediat
cathepsin
proteas
allow
effici
microb
prolifer
infect
anim
endocyt
infect
rout
retrovirus
might
chang
cell
surfac
infect
rout
escap
host
immun
mediat
endosom
cathepsin
proteas
instead
cathepsin
inhibitor
studi
indic
cathepsin
b
inhibit
infect
infect
occur
acid
endosom
particl
could
degrad
predominantli
cathepsin
b
viral
particl
intern
endosom
reduc
infect
addit
studi
specul
entri
host
cell
occur
acid
endosom
even
particl
intern
endosom
viral
entri
might
occur
virioncontain
endosom
becom
acid
compar
studi
infect
pave
way
clarif
novel
mechan
disclos
use
alreadi
report
hiv
env
mndk
rodb
express
plasmid
kindli
provid
dr
u
hazan
dr
p
r
clapham
env
strain
express
plasmid
kindli
provid
dr
yokomaku
vsvg
express
plasmid
phefvsvg
obtain
dr
l
chang
aid
research
refer
reagent
program
divis
aid
niaid
nih
usa
express
plasmid
encod
fusion
protein
constitut
activ
form
construct
research
group
previous
report
express
plasmid
domin
neg
mutant
provid
dr
benmerah
dr
j
tremblay
human
hela
cell
cultur
dulbecco
modifi
eagl
medium
wako
osaka
japan
cultur
media
supplement
fetal
bovin
serum
biosourc
rockvil
md
hela
cell
stabli
express
construct
follow
cell
transfect
express
plasmid
encod
hygromycinresist
gene
invitrogen
carlsbad
ca
select
hygromycin
invitrogen
hygromycinresist
cell
clone
express
select
fac
analysi
use
fitcconjug
antibodi
sigma
st
loui
mo
construct
cystatin
cexpress
cell
hela
cell
inocul
mlv
vector
encod
cystatin
c
origen
rockvil
md
previous
report
mlv
vector
addit
encod
puromycinresist
gene
inocul
cell
select
puromycin
sigma
puromycinresist
cell
pool
use
studi
construct
cathepsin
boverexpress
cell
cell
inocul
cathepsin
bencod
mlv
vector
select
puromycin
puromycinresist
cell
pool
use
studi
construct
hybridoma
cell
hela
cell
puromycinresist
hela
geneticinresist
cell
fuse
polyethylen
glycol
roch
indianapoli
select
simultan
puromycin
geneticin
invitrogen
doubl
antibioticsresist
cell
pool
use
studi
obtain
vector
particl
contain
env
protein
monkey
cell
transfect
packag
construct
laczcontain
vector
ptyefnlacz
appropri
env
express
plasmid
use
fugen
transfect
reagent
roch
transfect
cell
wash
medium
h
transfect
continu
cultur
fresh
medium
h
target
cell
pretreat
chloroquin
sigma
bafilomycin
sigma
sigma
dynasor
calbiochem
la
jolla
ca
h
compound
dissolv
dmso
sigma
cell
treat
equal
volum
dmso
control
pretreat
cell
inocul
cultur
supernat
vectorproduc
cell
inocul
cell
stain
xgal
wako
day
inocul
blue
cell
count
estim
transduct
titer
undilut
vector
contain
mndk
env
protein
induc
blue
cell
dmsotreat
cell
respect
undilut
mndk
vector
induc
blue
cell
dmsotreat
hela
cell
respect
therefor
vector
inocul
cell
vector
solut
dilut
normal
transduct
titer
undilut
vector
contain
rodb
env
protein
usual
induc
blue
cell
cell
blue
cell
origin
cell
therefor
rodb
vector
inocul
cell
vector
dilut
dmsotreat
affect
vector
infect
cdna
express
librari
prepar
human
lymph
node
commerci
obtain
takara
shiga
japan
hela
cell
transfect
cdna
express
librari
use
fugen
transfect
reagent
select
geneticin
invitrogen
geneticinresist
cell
pool
inocul
blasticidin
resist
geneencod
mndk
envbear
vector
vector
construct
transfect
cell
mndk
env
express
plasmid
togeth
blasticidin
resist
geneencod
vector
genom
express
plasmid
invitrogen
inocul
cell
select
blasticidin
invitrogen
blasticidinresist
cell
clone
analyz
studi
amplifi
cdna
sequenc
present
blasticidinresist
hela
cell
pcr
perform
use
genom
dna
sampl
prepar
cell
nucleotid
sequenc
pcr
primer
genenet
fukuoka
japan
gac
tca
cta
tag
gga
att
atc
tta
tca
tgt
ctg
gat
nucleotid
sequenc
pcr
product
determin
big
dye
termin
cycl
sequenc
kit
appli
biosystem
warrington
uk
access
number
nucleotid
sequenc
pcr
product
analyz
cell
surfac
express
suspend
cell
treat
rat
antibodi
control
serum
h
cell
wash
pb
time
treat
fitcconjug
antirat
igg
antibodi
sigma
stain
cell
appli
flow
cytomet
bd
bioscienc
san
jose
ca
measur
cathepsin
b
activ
live
cell
cell
stain
cathepsin
b
detect
reagent
cell
technolog
minneapoli
mn
reagent
util
fluorophor
cresyl
violet
bisubstitut
amid
linkag
peptid
contain
cathepsin
b
target
cleavag
sequenc
form
cresyl
violet
leav
group
nonfluoresc
follow
cleavag
amid
linkag
site
cathepsin
b
live
cell
mono
nonsubstitut
cresyl
violet
fluorophor
gener
red
fluoresc
stain
cell
subject
flow
cytomet
bd
bioscienc
measur
fluoresc
intens
measur
cathepsin
b
activ
cell
lysat
cathepsin
b
activ
assay
kit
biovis
mountain
view
ca
use
cathepsin
b
activ
assay
kit
fluorescencebas
assay
util
prefer
cathepsin
b
substrat
amino
acid
sequenc
label
coumarin
afc
cell
lysat
contain
cathepsin
b
cleav
synthet
afclabel
substrat
releas
free
afc
gener
fluoresc
cell
lysat
incub
cathepsin
b
substrat
assay
kit
h
fluoresc
intens
nm
measur
fluoresc
micropl
reader
perkinelm
turku
finland
cell
lysat
subject
sodium
dodecyl
sulfat
polyacrylamid
gel
electrophoresi
biorad
hercul
ca
transfer
onto
pvdf
membran
millipor
billerica
membran
treat
anticystatin
c
antiactin
antibodi
santa
cruz
biotechnolog
santa
cruz
ca
horseradish
peroxidaseconjug
protein
g
biorad
protein
gbound
polypeptid
visual
ecl
western
blot
detect
reagent
ge
healthcar
buckinghamshir
uk
total
rna
isol
cell
use
trisol
reagent
invitrogen
first
strand
cdna
synthes
total
rna
random
hexam
mean
revers
transcriptas
takara
semiquantit
pcr
perform
use
first
strand
cdna
templat
detect
cystatin
c
cathepsin
b
gapdh
mrna
nucleotid
sequenc
pcr
primer
genenet
cystatin
c
mrna
tag
ccg
acc
atg
tac
aga
ccc
cta
cathepsin
b
mrna
tac
caa
cac
gtc
acc
gcc
cac
ggc
aga
gapdh
mrna
tcg
gag
tca
acg
gat
ttg
ggc
cat
gag
gtc
cac
target
cell
pretreat
inhibitor
h
starv
presenc
inhibitor
h
transferin
jackson
laboratori
ad
incub
min
surfacebound
transferin
remov
trypsin
treatment
cell
min
fluoresc
intens
cell
measur
flow
cytomet
bd
bioscienc
differ
group
rel
valu
determin
student
ttest
correl
rel
valu
cathepsin
b
activ
suscept
mndk
vector
infect
analyz
spearman
rank
correl
level
statist
signific
set
p
test
